Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma
Glioblastoma (GBM) is an essentially incurable and rapidly fatal cancer, with few markers predicting a favourable prognosis. Here we report that the transcription factor NFIB is associated with significantly improved survival in GBM. NFIB expression correlates inversely with astrocytoma grade and is...
Main Authors: | Stringer, Brett W., Bunt, Jens, Day, Bryan W., Barry, Guy, Jamieson, Paul R., Ensbey, Kathleen S., Bruce, Zara C., Goasdoué, Kate, Vidal, Hélène, Charmsaz, Sara, Smith, Fiona M., Cooper, Leanne T., Piper, Michael, Boyd, Andrew W., Richards, Linda J. |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045397/ |
Similar Items
-
PAX6 does not regulate Nfia and Nfib expression during neocortical development
by: Bunt, Jens, et al.
Published: (2015) -
The impact of the MYB-NFIB fusion proto-oncogene in vivo
by: Mikse, Oliver R., et al.
Published: (2016) -
Eph receptors as therapeutic targets in glioblastoma
by: Day, B W, et al.
Published: (2014) -
Differential localization of glioblastoma subtype: implications on glioblastoma pathogenesis
by: Steed, Tyler C., et al.
Published: (2016) -
An overlapping set of genes is regulated by both NFIB and the glucocorticoid receptor during lung maturation
by: Lajoie, Mathieu, et al.
Published: (2014)